Synlogic Inc Stock, NASDAQ:SYBX
301 Binney Street, Suite 402, Cambridge, Massachusetts 02142
United States of America
Number of Employees: 72
Synlogic, Inc. engages in the discovery and development of Synthetic Biotic medicines. It focuses in Phenylketonuria, Enteric Hyperoxaluria, Immuno Oncology solid tumors, inflammatory bowel disease, and vaccines and other inflammatory programs. The company was founded by Jim Collins and Tim Lu on August 28, 2017, and is headquartered in Cambridge, MA.